Role of Preoperative Selective Portal Vein Embolization in Two-Stage Hepatectomy for Primary Hepatocellular Carcinoma

嵇武,马宽生,董家鸿,黄晓兰,何振平

DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2003.06.010

2003-01-01

Abstract:Objective To determine the possibility of two-stage hepatectomy for primary hepatocellular carcinoma (HCC) after preoperative selective portal vein embolization (POSPVE). Methods A total of 26 HCC patients were treated with percutaneous transhepatic POSPVE by fine needle under the guidance of ultrasonography. The embolizing material was composed of ethanol and idol oil at a ratio of 1/2, and 0.4 ml/kg was considered as the standard dosage. The average amount was 26.5 ml. The rate of success, adverse reactions, changes of hepatic function, hepatic lobe volume and rate of hepatectomy were determined. Results POSPVE was successfully performed in 24 patients. In those 21 whose right portal vein was embolized, the right liver volume decreased from 683.7 cm3 preoperatively to 657.4 cm3, 621.3 cm3 and 604.1 cm3 in 1, 2 and 3 weeks after the operation. Meanwhile, the left liver volume increased from 332.2 cm3 preoperatively to 343.7 cm3, 375.1 cm3 and 392.8 cm3 in 1, 2 and 3 weeks postoperatively. The rate of hepatectomy was eased from 66.3% preoperatively to 65.4%, 62.7% and 59.2% in 1, 2 and 3 weeks postoperatively. The adverse reactions included different degrees of pain of the liver area, nausea, vomiting, low fever and hepatic function decrease with elevation of hepatic enzyme and bilirubin. Two to 3 weeks later, hepatectomy was successfully performed in 12 patients (46.2%). Conclusions POSPVE increases the indications of hepatectomy for HCC and elevates the security of hepatectomy. Therefore, it has definite value of clinical practice.